Verge Genomics is a pioneering biotechnology company focused on transforming drug discovery using advanced artificial intelligence and human genomics. By leveraging one of the world's largest proprietary multi-omics databases sourced directly from human tissue, Verge aims to develop better drugs, faster, to address critical medical challenges such as ALS, Parkinson's Disease, and Frontotemporal Dementia. Their innovative approach bypasses traditional animal models in favor of an all-in-human, AI-powered platform that quickly moves drug candidates from research to clinic. Based in South San Francisco, Verge collaborates with industry leaders to revolutionize treatment options for devastating diseases.
Bioinformatics β’ Genomics β’ Drug Discovery β’ Neuroscience
11 - 50 employees
𧬠Biotechnology
π€ Artificial Intelligence
π Pharmaceuticals
π° $98M Series B on 2021-12
November 20
Vice President of Business Development at Verge Genomics; focusing on partnerships and market opportunities in biotech.
πΊπΈ United States β Remote
π΅ $245k - $285k / year
π° $98M Series B on 2021-12
β° Full Time
π΄ Lead
π° Business Development (BDR)